Palisade Bio Announces $4 Million Private Placement Priced At-The- Market Under Nasdaq Rules
02. Mai 2024 08:30 ET
|
Palisade Bio, Inc.
Carlsbad, CA, May 02, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI), a biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with...